Mountain West Clinical and Translational Research Infrastructure Network (CTR-IN) Pilot Grant program
The Office of Research and Economic Development is soliciting nominating packets for the Pilot Grant program. Up to four UI nominating packets will be approved by ORED for submission to the CTR-IN. At the request of the CTR-IN, we will accept packets on a rolling basis.
The CTR-IN Pilot Grant program provides research funding and a mentored pathway of milestones leading to publications and expansion of research skills to help faculty members achieve independent investigator status as reflected in the submission of an NIH R-type grant proposal (or equivalent) in clinical or translational research.
Pilot Grant can support existing programs to reach national competitiveness by addressing regional health disparities, and by helping new investigators and established basic scientists achieve success in clinical or translational research. For more details, .
CTR-IN pilot grants require the institution provide support for half (10% effort) of the requested primary investigator effort as voluntary uncommitted cost share. Researchers interested in submitting a packet must notify ORED so that the matching support can be negotiated with department heads. Please contact Michelle Wiest at [email protected] as soon as possible to indicate your interest in submitting a nominating packet. Please supply your department head’s contact information in the email.
Nominating packets must be submitted to the Office of Sponsored Programs electronically through EIPRS as a single PDF attachment no later than noon on Monday, Jan. 25, 2016.
Full proposals will be sent to the CTR-IN no later than Jan. 29, 2016. The CTR-IN will send invitations to investigators selected to submit full applications by Feb. 12.
The nominating packet must include:
- An NIH form - for the proposed PI including the required Personal Statement.
- An NIH form - See for the proposed PI.
- A summary of the proposed research of no more than one page with sufficient detail to establish that the research is clinical or translational.
- A summary of the Institutional Review Board status (IRB proposal in preparation, submitted or approved with a copy of the approval). If IRB approval is not required, the reason must be documented.
- A letter of support signed by your department chair indicating that at least half of the requested PI effort will be covered by the university if the CTR-IN Pilot Grant is awarded, as agreed to by the CTR-IN institutions.
- Identification of the project mentor and a letter of support from the proposed mentor indicating his or her willingness to work with the prospective PI.
Applicants must have a faculty-level appointment at a participating CTR-IN Institution. Early or new stage investigators are encouraged to apply. Established researchers wanting to move from basic science into translational or clinical research also are eligible to apply. Per IDeA program policy, an awardee may not be concurrently receiving research funding through other IDeA mechanisms (e.g., COBRE or INBRE).
Each participating institution has a biostatistician supported by CTR-IN to assist prospective investigators in developing their research ideas. This biostatistical support is provided free of charge. Participation of the CTR-IN biostatistician in the drafting of proposals, and as the biostatistical co-investigator, is mandatory. Michelle Wiest is the designated UI biostatistician.
Please ensure your proposal falls under the CTR-IN definition of clinical or translational research, found on the .